Home👥 Ohio State Pituitary Patient Symposium, July 13, 2019 – Scholarships Added

👥 Ohio State Pituitary Patient Symposium, July 13, 2019 – Scholarships Added

June 26, 2019June 26, 2019 MaryO Interviews, Meetings and ConferencesAcromegaly, Dr. Daniel Prevedello, Dr. Lawrence Kirschner, Dr. Maria Fleseriu, growth hormone, hypopituitarism, Ohio State University, Pituitary, radiation, Scholarships, transsphenoidal

Ohio State Pituitary Patient Symposium – SCHOLARSHIPS

**The PNA has secured additional funding that has allowed us to offer
a limited number of scholarships to pay for the cost of the symposium only.
ACT FAST AND REGISTER TO SECURE YOUR SPOT TODAY! **

Keynote Speaker: Maria Fleseriu, MD FACE

Registration Cost: Individual $40 Save $20 and register for 2: $60

Please email carol@pituitary.org to register!

*This registration is for the Patient Symposium only. The Ohio State University is offering a CME Course separate from our Symposium. For information on the CME course go to ccme.osu.edu

OSU Pituitary Symposium Agenda
Saturday, July 13, 2019
Patients and Family’s Track
Gabbe Conference Room – James L045

8:00 AM	Registration and Breakfast
8:20 AM	Welcoming Remarks and Introductions: The OSU Skull Base and Pituitary Team
	Lawrence Kirschner, MD, PhD
	OSUCCC – James
8:30 AM	Hypopituitarism: Pitfalls and Recommendations
	Maria Fleseriu, MD, FACE
	Oregon Health and Science University
9:00 AM	Trans-sphenoidal Approach: What to Expect? Post-Operative Complications
	Richard Carrau, MD
	OSUCCC – James
9:30 AM	Acromegaly: Why it Takes That Long to Diagnose? What are the Options?
	Lawrence Kirschner, MD, PhD
	OSUCCC – James
10:00 AM	Round Table Q & A
10:15 AM	Mid-Morning Break
10:30 AM	Growth Hormone Deficiency: Journey to Adulthood
	Robert Hoffman
	Nationwide Children’s Hospital
11:00 AM	Radiation Therapy? Difference Between Modalities and Possible Risks
	Dukagjin M Blakaj, MD, PhD
	OSUCCC – James
11:30 AM	Round Table Q & A
11:45 AM	Lunch Break and Patient’s Journey
12:45 AM	Surgical Approach: What to Expect
	Daniel Prevedello, MD
	Douglas Hardesty, MD
	OSUCCC – James
1:15 PM	Visual Complications of Pituitary/Sellar Lesion? Predictors of Outcome
	Abbe Craven, MD
	OSUCCC – James
1:45 PM	Round Table Q & A
2:00 PM	Pituitary Trivia
	Luma Ghalib, MD
	Brian Lee
	OSUCCC – James
2:30 PM	Pituitary Dysfunction: Effect on Mental Health and Family
	William Malarkey, MD
	OSUCCC – James
3:00 PM	Recovering from Trans-sphenoidal Surgery, Challenges for the Patient and their Families
	Traci Douglass, RN
	OSUCCC – James
3:30 PM	Pituitary Network Association: Cushing’s Disease: Psychological Research and Clinical Implications
	Jessica Diller Kovler, AM, MA, PhD
	PNA Board Member
4:00 PM	Closing Remarks
4: 15 PM	Adjourn

Leave a ReplyCancel reply

🖤 In Memory: Millie Niss ~ November 29, 2009
Millie is the first Cushing’s patient that I know of to have died from complications from Swine Flu. She was only 36. Millie developed a confirmed case of the H1N1 virus. She spent 29 days in the ICU of Millard Suburban Hospital before dying of complications of the flu, compounded by Behcet’s Disease and Cushings […]
🖤 In Memory: Hermina Dala ~ November 29, 2002
Hermina had Cushing’s Disease. She passed away November 29, 2002.
‼️ Message Board Upgrade (and new features!) is coming this weekend
This is our November maintenance release. Key changes include the removal of the AdminCP Marketplace. Please see our announcement here. Also included: 4.7.13
📞 Webinar: Dr. Friedman Webinar on Optimal replacement for Hypopituitarism and Sheehan’s
December 6, Dr. Theodore Friedman (the Wiz) will be giving a webinar on Optimal replacement for Hypopituitarism and Sheehan’s: Oxytocin, testosterone, growth hormone, stimulants and beyond Learn what most Endocrinologists don’t know about but will improve your quality of life
📰 Adrenocorticotropin-Dependent Ectopic Cushing's Syndrome: A Case Report
The diagnosis of Cushing's Syndrome is a three-step process that includes its suspicion based on the patient's laboratory and semiologic findings, the documentation of hypercortisolism, and the identification of its cause, which can be either ACTH-dependent or independent.
✍️ Giving Thanks: Day Nineteen
I am thankful, believe it or not, that I had Cushing’s. Mind you, I wouldn’t want to have it now, although diagnoses and surgeries seem “easier” now. Having Cushing’s taught me a lot, including how to stick up for myself, how to read medical books to learn more about my disease, how to do web […]
📰 Interpetrosal Sphingosine-1-Phosphate Ratio Predicting Cushing’s Disease Tumor Laterality and Remission After Surgery
Cushing’s disease (CD) poses significant challenges in its treatment due to the lack of reliable biomarkers for predicting tumor localization or postoperative clinical outcomes. Sphingosine-1-phosphate (S1P) has been shown to increase cortisol biosynthesis and is regulated by adrenocorticotropic hormone (ACTH).
❣️Favorites on the Message Boards ❣️
Top hand-picked content from across the community.
🎂Happy birthday Dr. Friedman!
Happy birthday Dr. Friedman! Thank you for all you do and for the incredible impact you are making in the world! Join us in wishing Dr. Friedman a joyous and healthy year ahead!
📰 Bilateral Inferior Petrosal Sinus Sampling: Validity, Diagnostic Accuracy in Lateralization of Pituitary Microadenoma, ind Treatment In Eleven Patients with Cushing’s Syndrome – a Single-Center Retrospective Cohort Study
This study suggests that BIPSS may be a reliable and low-complication technique in evaluating patients with ACTH-dependent CS who had inconclusive imaging and biochemical test results. The diagnostic accuracy is improved by DDAVP stimulation. Pituitary adenoma lateralization can be predicted with the aid of BIPSS.

%d bloggers like this: